Terveystalo Oyj (HLSE:TTALO) Reported Lower Sales And Profit, Is The Stock Still Cheap?
Terveystalo Oyj (HLSE:TTALO) drew investor attention after reporting second quarter and half-year 2026 results, with both sales and net income lower than a year earlier.
See our latest analysis for Terveystalo Oyj.
Terveystalo Oyj's latest earnings have come against a backdrop of weaker momentum in the share price, with a 30 day share price return down 7.35% and the year to date share price return down 26.69%. However, the 3 year total shareholder return is still positive at 9.46%, suggesting the longer term picture has been more resilient than the recent pullback.
If Terveystalo's recent move has you reassessing your watchlist, this could be a good time to look at other healthcare related opportunities via our screener for 129 healthcare AI stocks.
The latest earnings setback and share price slide could be read as a verdict on Terveystalo Oyj's business, or simply a reset in sentiment after a stronger multi year run. So how does the current valuation stack up against those mixed signals?
Most Popular Narrative: 23.3% Undervalued
The most followed narrative on Terveystalo Oyj points to a fair value of €9.20 per share compared with the last close at €7.06. This frames the current discount through a detailed set of long term assumptions.
The introduction of the Kela 65 scheme, which allows Finnish citizens over 65 to access private healthcare at public prices, is expected to materially increase patient volumes for Terveystalo, leveraging demographic shifts and supporting sustainable revenue growth and a positive margin impact due to healthy appointment pricing.
Analysts have built a full earnings path around this kind of volume uplift, margin rebuild, and future valuation multiple. You can explore which mix of growth, profitability and discount rate assumptions needs to hold for Terveystalo Oyj to reach that fair value and align with the latest price target cuts.
Result: Fair Value of €9.20 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the Terveystalo Oyj narrative also faces pressure from softer occupational health demand and higher labor costs, which could squeeze margins and limit contract wins.
Find out about the key risks to this Terveystalo Oyj narrative.
Next Steps
With mixed signals on Terveystalo Oyj and sentiment clearly split between risks and rewards, it makes sense to check the detail yourself and act while the information is fresh. You can start with the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Terveystalo Oyj?
If Terveystalo Oyj is already on your radar, do not stop there. Broaden your opportunity set with fresh ideas that match your investing style and risk comfort.
- Target potential mispricings by scanning 245 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their current financial profile.
- Strengthen your income stream by reviewing 459 dividend fortresses that focus on higher yielding companies with the potential to complement your existing holdings.
- Dial down portfolio stress by assessing 293 resilient stocks with low risk scores that may bring more stability and help balance out your higher volatility positions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com